At a glance
ClinicalIndex Comparison RecordN/ACompleted· 47 enrolled
Drug / intervention
Oxytocin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Intranasal Neuropeptide on Emotion Perception in Trait Anxiety
In Brief
A clinical study evaluating Oxytocin and Placebo for Social Intelligence. Completed, enrolled 47 participants across 1 site.
Detailed Summary
The purpose of this study is to learn more about how emotional processing may be affected by a hormone called oxytocin. Oxytocin is a hormone that occurs naturally in the body, and may play an important role in the way that the brain perceives information.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSocial Intelligence
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedMar 2012
Primary CompletionDec 2012
TodayJul 2026
First PostedMar 12, 2012
Enrollment StartFeb 1, 2009
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 14.3 years ago
Interventions
Oxytocindrug
Liquid metered-dose nasal spray, 30 IUs, administered once.
Placebodrug
Matched nasal spray placebo